Phillip Frost

Phillip Frost

Chief Executive Officer at OPKO HEALTH, INC.

Net worth: 492 M $ as of 2024-03-30

87 year
Health Technology
Finance
Consumer Services

Profile

Dr. Phillip Frost, MD, is Chairman & Chief Executive Officer at OPKO Health, Inc., Chairman at Teva Pharmaceutical Industries Ltd., Chairman of the Investment Committee at Peregrine Ventures, Chairman at Ladenburg Thalmann & Co., Inc., Chairman at Ladenburg Thalmann Financial Services, Inc., Chairman at Temple Emanu-El, a Member at The Florida Council of 100, a Member at Frost Group LLC, and Chairman at Lachema as. He is on the Board of Directors at Castle Brands, Inc., Mount Sinai Medical Center, University of Miami (Florida), Miami Jewish Home & Hospital for The Aged, Tel-Aviv University, Cocrystal Discovery, Inc., Fabrus, Inc., Morgan Solar, Inc., TransEnterix, Inc., Frost Gamma Investments Trust, and Smithsonian Institution. Dr. Frost was previously employed as Chairman by Ideation Acquisition Corp., Chairman by PROLOR Biotech, Inc., Chairman & Chief Executive Officer by eXegenics, Inc., Chairman by IVAX Diagnostics, Inc., Co-Vice Chairman & Governor by American Stock Exchange LLC, Chairman & Chief Executive Officer by IVAX Corp., Chairman by Key Pharmaceuticals, Inc., Chairman-Dermatology Department by Mount Sinai Medical Center of Florida, Inc., Chairman by Whitman Education Group, Inc., Chairman & Chief Executive Officer by IVAX Pharmaceuticals, Inc., Chairman & Chief Executive Officer by Sorrento Therapeutics, Inc., General Partner & Investment Committee Member by Incentive Technological Incubator Ltd., a Trustee by The Scripps Research Institute, and Vice Chairman by North American Vaccine, Inc. He also served on the board at BioZone Pharmaceuticals, Inc., SafeStitch Medical, Inc., Orthodontix, Inc., Cellular Technical Services Co., Inc., Continucare Corp., Northrop Grumman Corp., Protalix Biotherapeutics, Inc., Smithsonian Institution, and TransEnterix, Inc. He received his undergraduate degree from the University of Pennsylvania and a doctorate degree from the Albert Einstein College of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-17 244,164,353 ( 35.03% ) 293 M $ 2024-03-30
2023-06-01 14,763,520 ( 9.36% ) 162 M $ 2024-03-30
2023-06-01 7,550,619 ( 8.25% ) 12 M $ 2024-03-30
2024-02-11 18,884,874 ( 23.21% ) 9 M $ 2024-03-30
2024-03-25 3,428,571 ( 18.31% ) 5 M $ 2024-03-30
2023-09-10 1,250,000 ( 11.90% ) 4 M $ 2024-03-30
2024-01-15 5,100,253 ( 3.48% ) 4 M $ 2024-03-30
2024-04-09 1,319,838 ( 12.97% ) 2 M $ 2024-03-30
2023-10-29 54,690,325 ( 35.33% ) 1 M $ 2024-03-30
2024-03-25 1,286,454 ( 4.96% ) 523 587 $ 2024-03-30
2022-12-31 100,000 ( 0.46% ) 18 800 $ 2023-12-30
2023-02-22 45,618 ( 1.69% ) 7 755 $ 2024-03-30

Phillip Frost active positions

CompaniesPositionStart
OPKO HEALTH, INC. Chief Executive Officer 2007-03-26
COCRYSTAL PHARMA, INC. Director/Board Member 2014-01-01
NON-INVASIVE MONITORING SYSTEMS, INC. Director/Board Member 2023-05-31
Director/Board Member 2012-12-10
Director/Board Member -
Frost Gamma Investments Trust Director/Board Member -
Phillip & Patricia Frost Philanthropic Foundation, Inc. President -
Director/Board Member -
Director/Board Member -
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
All active positions of Phillip Frost

Former positions of Phillip Frost

CompaniesPositionEnd
░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Phillip Frost's experience

Training of Phillip Frost

University of Pennsylvania Undergraduate Degree
Albert Einstein College of Medicine, Inc. Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Phillip Frost's experience

Connections

100 +

1st degree connections

54

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies8
NON-INVASIVE MONITORING SYSTEMS, INC.

Finance

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Health Technology

NORTHROP GRUMMAN CORPORATION

Electronic Technology

PROTALIX BIOTHERAPEUTICS, INC.

Health Technology

OPKO HEALTH, INC.

Health Services

FLUENT, INC.

Technology Services

ASENSUS SURGICAL, INC.

Health Technology

COCRYSTAL PHARMA, INC.

Health Technology

Private companies41

Health Technology

eXegenics, Inc.

Health Technology

Whitman Education Group, Inc.

Consumer Services

Finance

Health Technology

Orthodontix, Inc.

Finance

Health Services

Finance

Health Technology

Commercial Services

Consumer Non-Durables

Health Technology

Finance

Finance

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Consumer Services

Health Services

Finance

Health Services

Health Technology

Finance

The Florida Council of 100

Finance

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Finance

Phillip & Patricia Frost Philanthropic Foundation, Inc.

Miscellaneous

Frost Gamma Investments Trust

Miscellaneous

Health Services

Health Technology

See company connections